The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback